Role of insulin, insulin sensitivity, and abomasal functions monitors in evaluation of the therapeutic regimen in ketotic dairy cattle using combination therapy with referring to milk yield rates.

Background: Ketosis is one of the most critical metabolic disorders that occur in dairy cows after parturition due to negative energy balance around calving. Aim: The study evaluated a specific therapeutic regimen of ketosis in Holstein dairy cattle by using the combination therapy including hormones, corticosteroids, propylene glycol, and vitamin B12 as well as the use of milk yield rates, insulin, insulin sensitivity, and abomasal functions monitors as diagnostic biomarkers for the recovery of ketotic cows either pre-therapy (0 days) or post-therapy (7 and 14 days).
Methods: This study was conducted on ketotic cattle (n = 20) belonged to different dairy farms in Cairo and Giza governorates, Egypt. The diseased cows were undergoing clinical and biochemical investigations for the estimation of serum insulin. Quantitative Insulin Sensitivity Check Index (RQUICKI) and abomasal functions monitor mainly serum levels of gastrin, pepsinogen, and chloride.
Results: The milk production rates, cost: benefit analysis ratio, and benefit of the dairy farm in ketotic animals were significantly increased post-treatment. An improvement of insulin sensitivity was stated as serum insulin, and RQUICKI were remarkably increased in post-therapeutic ketotic cows. Monitors of the abomasal function revealed abomasal functions improvement through the significant elevation of blood gastrin and a substantial reduction in serum pepsinogen due to treatment.
Conclusion: The study revealed high efficacy of the applied therapeutic strategy regime. It led to a high recovery rate and a very low relapse rate for ketosis. An improvement in milk yield rates, insulin sensitivity, and abomasal function monitors was reported. Hypoinsulinaemia was still reported, however, serum insulin was improved.

Introduction

The postpartum period of the dairy cows is critical in the production life of the cow during this time; where dairy cows are at risk of certain diseases such as metritis, abomasal displacement (DA), and ketosis (Curtis ; Khalphallah ; Khalphallah ).

The most common diseases of transition periods reported at the first 50 days in milk (DIM) in dairy cattle included retained placenta, ketosis, DA, milk fever, mastitis, and dystocia. Retained placenta, ketosis, and DA, i.e., energy-related diseases, were sometimes associated with one or more disease states such as milk fever, mastitis, and dystocia (Khalphallah ). Iwersen and Khalphallah added that retained placenta, ketosis, DA, milk fever, mastitis, and dystocia were the most commonly reported diseases of transition periods (50 DIM) in dairy cattle.

Ketosis is one of the most critical metabolic disorders that occur in dairy cows after parturition due to negative energy balance (NEB) around calving (Cameron ). From the possible ways in the diagnosis of ketosis are evaluating clinical findings including (rectal temperature, pulse rate, respiratory rate, and ruminal movement) also monitoring of body condition score (BCS) are vital to evaluate the nutritional and health status of animals (Upham, 1996).

Secondary, or type II, ketosis occurs earlier in lactation than type I ketosis and is usually concurrent with other diseases (Holtenius and Holtenius, 1996). Hyperketonemia and varying serum glucose and insulin concentrations were reported in ketotic cattle (type II). Affected cows were often over-conditioned (Agenäs ).

Insulin facilitates the cellular uptake of glucose and downregulates adipose tissue mobilization. Insulin concentration is high before calving and declines to low levels after parturition (Kokkonen ; Van Knegsel ), so the low postpartum concentration of insulin stimulates adipose tissue breakdown to counteract the NEB in early lactation.

Insulin resistance is a multi-factorial phenomenon characterised in humans by metabolic acidosis, hyperglycaemia, glucose intolerance, glucosuria, ketonaemia, ketonuria, diuresis, hypovolaemia, dehydration, polydipsia, central nervous system depression, and shock (McCance and Huether, 1994). These physiopathological events are also seen in ruminant animals with induced or spontaneous hepatic lipidosis and ketosis (DeBoer ; Veenhuizen ; Drackley, 1999).

The previous reports concerned with the monitoring of abomasal functions in ketotic cattle associated with DA through the estimation of serum levels of gastrin and pepsinogen (Khalphallah ). Other studies mentioned a strong association between many postpartum diseases such as ketosis and increase risk of DA (Curtis ; Duffield and Bagg, 2002) as well as serum pepsinogen and gastrin showed variable changes due to DA only or DA with ketosis problems (Ozturk ; Khalphallah ); therefore, the current study needed to focus on this relationship between ketotic cows and blood gastrin, pepsinogen, and chloride.

Several articles referred to the efficacy of different therapeutic regimens in the treatment and management of ketosis in dairy cattle that were reported at different lactation stages (Tufani ) as some used complex treatment regimens (Tufani ; Madreseh-Ghahfarokhi ) where others used simple treatments (Radostits ; McArt ).

In cattle, several effective treatments were available for ketosis, but in some affected animals, the response was only transient; in rare cases, the disease might persist and cause death or necessitate the animals' slaughter (Constable ).

The prognosis and response to therapy were related to the type of ketosis. Ketosis (type I) that occurred at the peak of lactation usually responded quickly to the treatment, but relapses were common if the diet was not corrected. Periparturient ketosis (type II) responds less rapidly to treatment (Anderson and Rings, 2009).

Therefore, the present study aimed to evaluate a specific therapeutic regimen of ketosis in Holstein dairy cattle by using combination therapy including hormones, corticosteroids, propylene glycol, and vitamin B12, through the innovative use of insulin, insulin sensitivity, and abomasal functions monitors (Serum gastrin, pepsinogen, and chlorides) as diagnostic biomarkers for the recovery of ketotic cows either pre-therapy (0 days) or post-therapy (7 and 14 days) as well as estimation of milk yield rates.

Materials and Methods

Animals

The study was conducted on ketotic Holstein dairy cattle (n = 20) belonged to different dairy farms in Cairo and Giza governorates, Egypt. Their body weight ranged between 350 and 400 kg, and age ranged between 3 and 5 years. The average 305-days milk yield was approximately 4,600 kg. They were fed on total mixed ration (TMR). The one cow consumed about 18–19 kg TMR. The farm's system was a tie stall. Milking times were two; 6 am and 6 pm. The diseased cattle were subjected to a therapeutic strategy extended to 5 days to relieve them from ketosis. All cattle were examined and sampled at day 0 (pretreatment) then at days 7 and 14 post-treatment. 0-day pretreated ketotic group was considered as a control group.

Samples

Blood serum samples were collected from the jugular vein on plain vacutainer tubes and stored at −20 Ċ until analysis. The animals were sampled at day 0 before treatment and days 7 and 14 following treatment.

Therapeutic strategy

Diagnosis of all ketotic cows was mainly based on clinical findings and estimation of serum β-hydroxybutyric acid (BHBA) at day 0 (lactating cows 5–50 days in milk). The diseased animals were either subclinically ketotic cows (SCK) in which serum BHBA levels were 1.2–2.4 mmol/l or clinically ketotic ones (CK) in which serum BHBA levels were ≥2.5 mmol/l. This classification was according to Sakha and Tehrani-Sharif .

The diseased cattle were treated at day 0 after clinical examination, and serum sample collection was conducted before the first treatment, according to Radostits and Constable . The treatment continued for successive 5 days as following: The IV injection of 500 ml of a 50% solution of glucose (5%® El Fath for Pharmaceutical and Cosmetics Industries (FIPCO), Cairo, Egypt) q24h alternatively with IV injection of 500 ml of a 50% dextrose solution (Dextrose 50%® VETWIC, Cairo, Egypt) for 5 successive days. Drenching with propylene glycol as glucose precursor, i.e., propane-1, 2-diol, once or twice daily for successive 5 days. The traditional dose is 300 ml twice daily for 2 days, followed by 150 ml once daily for 3 days to cattle. Treatment continued for 5 days until feed intake improved [El Nasr Pharmaceutical Chemical Co., Cairo, Egypt]. Dexamethasone [Dexamethasone® ADWIA Co., Cairo, Egypt] as glucocorticoid administration [0.04 mg/kg (20 mg/450 kg) of Dexamethasone IM once daily every other day], following adequate fluid volume replacement (IV 50% solution of glucose), steroids were given as a single IM injection over a 1–3 minutes’ period. The treatment should continue for successive 5 days/3 doses. Insulin (Mixtard® 30 HM Vial 100 IU/ml, Novo Nordisk A/S, Denmark) was administered in conjunction with glucose and glucocorticoid (Dexamethasone). The dose of Mixtard ®30 HM was 2 ml (200 IU) per animal administered SC every 48 hours for 5 days. 1 vial contained 10 ml (1,000 IU). The animals were treated with IV 50% glucose solution, IM dexamethasone, and SC Insulin together in alternation with IV 50% dextrose. Vitamin B12 (KENAZAL® 10 solution, KENANA) was administered 5 ml/100 kg IM every other day three times (days 1, 3, and 5). The feed additive, i.e., Smartamine (Smartamine® M, Kemin company, Des Moines, IA, imported by United Bio-med Co., Cairo, Egypt) in a dose of 15 g daily, per os, for successive 60 days. Smartamine included amino acids (methionine and lysine).

Clinical examination

All animals underwent a thorough clinical examination as described by Cockcroft (2015). The animals were examined on day 0 before treatment and days 7 and 14 following treatment. BCS of all cows was measured depended on a 5-point scale (Ferguson ). Rates (per kg) and cost (US $) of milk production for each cow were estimated either pre-therapy or post-therapy. Furthermore, the price (US $) of milk production (kg) per cow was estimated after adding the cost of therapy per ketotic cow at 0 days. Cost: benefit analysis (per cow) = cost of milk production per cow per day [with (at day 0) or without (at days 7 and 14) the fees of strategic treatment] / benefit of milk production per cow per day was determined for each cow at each sampling time. Benefit (US $) was estimated by subtraction cost of milk production per cow per day (with or without the fees of strategic treatment) from the sale price of milk production per cow per day. The sum (US $) of each of the benefits, cost of milk production, and sale prices of milk yield for all investigated cows were also measured at each sampling time.

Laboratory examination

Serum samples were collected, and all precautions for collection and preparation of samples to ensure accurate evaluation of biochemical indices, as described by Coles (1986), were taken into consideration. Serum biochemical assays were estimated at day 0 before treatment and days 7 and 14 following treatment.

Serum BHBA was measured for all cows only at day 0 by using the kinetic enzymatic method by the Optizen 32,220 UV/Visible spectrophotometer (Mecasys Co., Ltd. South Korea) with commercial kits (Ranbut, Randox Ltd, UK).

Insulin was measured using a commercial ELISA kit supplied by CALBIOTECH, the USA, imported by a beta-diagnostic company, Egypt.

Quantitative Insulin Sensitivity Check Index (RQUICKI values) was based on fasting plasma glucose, insulin, and non-esterified fatty acid (NEFA), and a low value indicates decreased insulin sensitivity. RQUICKI as a metabolic index was estimated= 1/ [log10 (glucose, mg/dl) + log10 (insulin, μU/ml) + log10 (NEFA, mmol/l)] (Perseghin ; Rabasa-Lhoret ). Serum levels of glucose (Glucose, Gamma Trade Company, Egypt) and NEFAs (NEFA, Randox Ltd, UK) were determined using the Optizen 32,220 UV/Visible spectrophotometer (Mecasys Co., Ltd. South Korea) with commercial kits.

Serum gastrin levels were determined by double-antibody gastrin 125I radioimmunoassay (RIA Kit, DPC, USA) according to Kataria .

Serum pepsinogen was determined by sandwich enzyme-linked immunosorbent assay (ELISA- Sandwich Protocol) using commercial kits (Bovine Pepsin A (PGA) ELISA Kit, AssayGenie, Dublin, Ireland).

Serum chlorides were determined using Optizen 32,220 UV/Visible spectrophotometer (Mecasys Co., Ltd. South Korea) with reagent kits (Spinreact Company, Spain).

Statistical analysis

Computer Software (SPSS version 16.0, Chicago, IL) was used to analyse all obtained data. Data were shown as mean ± standard deviation values. The data obtained from clinical examination and biochemical analyses were analysed by general linear model repeated measures analysis of variance, and the significance level of results was set at p < 0.05. The significance of differences was evaluated between the means at selected sampling days (days 0, 7, and 14).

Ethical approval

All experimental protocols were approved by Institutional Animal Care and Use Committee guidelines of Assiut University which were in accordance with the Guide for Laboratory Animals Care and Use of the National Institutes of Health in the USA (NIH publication No. 86–23, revised 1996).

Results

The ketotic cattle were usually considered risk factors for many postparturient diseases such as retained placenta, DA, and/or mastitis. Out of the 20 (100%) cows, 8 (40%) were suffering from DA, 5 (25%) were suffering from the retained placenta, 2 (10%) were suffering from mastitis, and 5 (25%) of the cows had no complications.

The clinical findings in diseased ketotic cows, including temperature, pulse rate, and respiratory rate (Table 1), showed no significant changes between days 0 (pre-treatment), 7, and 14. All clinical findings values were within the physiological reference range. Ruminal movement values in diseased ketotic cows (Table 1) showed significant improvement (p < 0.05) at days 7 and 14 (post-treatment) when their values were compared with those at day 0 (pre-treatment).

Table 1.

Mean values of body weight, temperature, pulse, respiration and rumen movement in pretreated and post-treated ketotic cows (n = 20).

Groups	Temperature (38.5°C–39.5°C)a or (38.0°C–39.0°C)a	Pulse (Beat/minutes) (60–80)a	Respiration (/minutes) (10–30)a or (15–30)a	Rumen (cycle/2 minutes) (2–4)a	BCS (2.5–4)a
0 day pretreated ketotic group	38.68 ± 0.45b	81.55 ± 8.65b	23.30 ± 3.37b	1.6 ± 0.68c	3.18 ± 0.46b
7 days post-treated ketotic group	38.69 ± 0.17b	80.40 ± 7.16b	22.95 ± 4.08b	2.90 ± 0.31b	3.06 ± 0.35c
14 days post-treated ketotic group	38.66 ± 0.13b	79.70 ± 5.07b	22.45 ± 3.56b	2.90 ± 0.31b	2.925 ± 0.28cd

BCS = body condition score.

Adapted from Radostits , Jackson and Cockcroft (2002), Ferguson .

Means of different superscript letters are significantly different (p < 0.05).

BCS in ketotic cows showed a significant decrease (p < 0.05) at days 7 and 14 (post-treatment) when compared with their values at day 0 (pre-treatment). This substantial reduction in BCS was also reported at day 14 when their values compared with those at day 7. BCS values still within the physiological reference values (Table 1).

The rates of milk production (kg) in diseased animals (Table 2) were significantly increased (p < 0.05) at days 7 and 14 post-treatment when they were compared with their values at day 0 (pre-treatment). This significant elevation (p < 0.05) in mean values of milk production was also reported between days 7 and 14 when values at day 14 compared with those at days 7. These findings confirm the impact of treatment in improving the health and productivity states of ketotic cows.

Table 2.

Mean values of cost: benefit analysis, benefit, cost and sale price of milk production in pretreated and post-treated ketotic cows (n = 20).

Groups	Milk production (kg)	Cost: benefit analysis cow/day	Benefit due to increased milk production (US $)		Cost of milk production (US $)		Sale price of milk production (US $)
			Cow/day	Sum of benefits	Cow/day	Sum of cost	Cow/day	Sum of sale price
0 day pretreated ketotic group	14.25 ± 1.58c	−9.330 ± −5.238b	−0.968 ± −0.275c	−19.37	7.843 ± 0.513a	156.868	6.876 ± 0.764c	137.500
7 days post-treated ketotic group	18.00 ± 1.80b	1.909a	3.003 ± 0.288b	60.04	5.732 ± 0.551b	114.620	8.734 ± 0.839b	174.660
14 days post-treated ketotic group	24.38 ± 1.25a	1.909a	4.044 ± 0.208a	80.87	7.718 ± 0.395a	154.371	11.762 ± 0.602a	235.240

Means of different superscript letters are significantly different (p < 0.05).

Cost: benefit analysis reported a significant (p < 0.05) increase at day 0 (−9.330 ± −5.238) compared with those at days 7 (1.909) and 14 (1.909). The benefit (US $) of the dairy farm due to increased milk production per cow as a result of the success in therapeutic strategy regimen of ketosis showed a remarkable (p < 0.05) elevation post-therapy at days 7 (3.003 ± 0.288) and 14 (4.044 ± 0.208) compared with values of pre-therapy benefit (−0.968 ± −0.275) at day 0. The sum of sale prices (US $) of milk production of all investigated dairy cows was improved due to therapy at days 7 (174.660) and 14 (235.240) compared with those at day 0 (137.500) (Table 2).

Blood insulin levels showed a remarkable increase (p < 0.05) in post-treatment cows at days 7 and 14 when their values compared with that at day 0 (pre-treatment). This significant elevation in insulin levels was also shown on day 14 compared with that on day 7 (Table 3). Insulin concentrations were gradually increased after treatment on day 0, however, their values did not reach the reference values on days 14.

Table 3.

Mean values of serum insulin, RQUICKI, gastrin, pepsinogen and chloride in pretreated and post-treated ketotic cows (n = 20).

Groups	Insulin (μU/ml) (5.8–7.6 or 7.7–9.5)a	RQUICKI [0.45–0.48 (0.46)a	Gastrin (pg/ml = ng/l) (36.37–44.63)a or (103.2)a	Pepsinogen (mU) (900–1,200)a	Chloride (mmol/l) (95–110)a
0 day pretreated ketotic group	1.12 ± 0.26b	0.44 ± 0.06b	197.18 ± 66.61b	1102.58 ± 239.5134c	98.2 ± 6.12c
7 days post-treated ketotic group	2.43 ± 1.56d	0.61 ± 0.10c	304.41 ± 68.54d	1016.56 ± 289.32[ab]	101.90 ± 4.97a
14 days post-treated ketotic group	4.54 ± 2.32a	0.55 ± 0.09b	422.53 ± 102.82a	914.21 ± 233.03b	99.70 ± 3.67a

BCS = body condition score.

Adapted from Holtenius and Holtenius (2007), Stengärde , Perry , Ok , Ohwada , Radostits .

Means of different superscript letters are significantly different (p < 0.05).

The RQUICKI (Table 3) were remarkably increased (p < 0.05) in ketotic cows at days 7 and 14 (post-treatment) compared with the values at day 0 (pre-treatment). The elevation in RQUICKI values with treatment (at days 7 and 14) in ketotic cows indicated an improvement in insulin sensitivity and the success of ketosis's therapeutic program. Post-treated RQUICKI values were higher than the reference values.

The reported results mentioned that several changes in abomasal functions monitors, including gastrin, pepsinogen and chlorides. Generally, an improvement of the abomasal functions was reported. Serum gastrin levels (Table 3) in diseased ketotic cows throughout the present study, either before or after treatment, were higher than the reference values of blood gastrin in cows. Serum gastrin value was significantly increased (p < 0.05) in post-treated ketotic cows at days 7 and 14 compared to day 0.

Serum pepsinogen concentration was remarkably (p < 0.05) reduced after therapy, particularly on day 14 (Table 3). However, the pepsinogen levels were still within the physiological reference range.

There were no significant changes in serum levels of chloride (Table 3) within the physiological reference range during the entire study period.

Discussion

Ketosis was one of the common metabolic diseases of the periparturient period as it was associated with several concurrent diseases and economic losses. CK and SCK were described (Dohoo and Martin, 1984; Dohoo ). Iwersen mentioned that SCK often was still hidden in the absence of clinical findings, and the true prevalence was underestimated in dairy herds. Ketosis had damaging effects on healthy cow performance, productivity and reproductivity.

The current results found that ketotic cattle were usually considered risk factors for many postparturient diseases such as retained placenta, DA and/or mastitis. Khalphallah added that retained placenta, ketosis, DA, milk fever, mastitis and dystocia were the most commonly reported diseases of transition periods (50 DIM) in dairy cattle. Ketosis, DA and retained placenta as energy-related diseases were sometimes related to one or more of each milk fever, mastitis, and/or dystocia. Curtis and Duffield and Bagg (2002) said that herds with ketosis (SCK) in early lactation cows were at an increased frequency of DA.

The previous articles revealed that ketosis predisposed cows to other diseases and reproductive disorders and was associated with depressed milk production. Despite energy-rich feed rations, NEB frequently developed in dairy cattle's periparturient period (Hejel ). Reduction of dry matter intake during early lactation and the energy and fat and protein demands were increased; therefore, cows mobilised body fat to meet the lactation needs (Cao ).

The clinical findings in diseased ketotic cows showed no significant changes in temperature, pulse, and respiration indices at day 0 (pre-treatment) and at days 7 and 14 (post-treatment). All clinical findings values were still within the physiological reference range reported by Radostits and Jackson and Cockcroft (2002). The ruminal cycle in diseased ketotic cows (pretreated) revealed a remarkable decrease compared to the physiological reference range reported by Radostits . This might be due to the effect of ketogenic acids on rumen movement; after treatment at days 7 and 14, the rumen cycle values significant increase but still within the physiological reference range reported by Radostits . These findings agreed with Tufani , who added that a characteristic sweetish odour of the breath, milk and urine was reported in most cases.

The mean values of milk production showed a significant increase at days 7 and 14 (post-treatment) compared with those at day 0, reflecting the role of treatment regimen in improving both productivity and health condition of cows. The milk production was sharply decreased at day 0 then improved after treatment. Edwards and Tozer (2004) reported that ketosis was usually associated with moderate to marked decline in milk yield over 5-6 days before the onset of obvious clinical signs that can persist (up to 5 l per day) 2 weeks after diagnosis.

Regarding the success of the ketosis therapeutic program in the current article, which was reflected through the significant increase in milk production per cow as well as the exclusion of fees of therapeutic regimen (at days 7 and 14), the cost: benefit analysis reported a significant reduction post-therapy (days 7 and 14). This indicated the low cost and high benefit. The high benefit was due to a significant elevation in milk yield per cow per day and the zero cost of therapy. Therefore, the dairy farm's benefit showed also a remarkable elevation post-therapy compared with those on day 0 (pre-therapy). Van Winden and Kuiper (2003) and Khalphallah reported economic losses due to milk loss, cost of treatment and increased culling rate either in DA SCK or DA CK. On the other side, the present study added that the sum of sale prices of all investigated dairy cows' milk production was improved due to therapy and due to the significant improvement in milk yield. These findings supported by McArt , who said that cows that had SCK within the first-week post-calving (3–7 DIM) produced less milk (Produced 2.2 kg less milk per day) in the first 30 DIM than cows developing SCK after the first week of lactation (at 8 DIM or later).

BCS values in ketotic cows either before treatment at day 0 or after treatment at days 7 and 14 were within the physiological reference range reported by Ferguson . These results relatively were supported by Khalphallah , who stated that BCS was not significantly changed either in close-up or post-fresh periods when its values in control cattle were compared with those of diseased one. Edwards and Tozer (2004) mentioned that ketosis was usually associated with a gradual drop of body condition over several days or weeks. Previous studies reported that most dairy cows face NEB in early lactation; postpartum feed intake was lower in cows with higher BCS prepartum, leaving them in NEB for a more extended period than cattle with normal or low BCS (Hayirli ).

The insulin concentrations were gradually increased with therapy after treatment at day 0, however, their values did not reach the reference values which were reported by Holtenius and Holtenius (2007) at days 14 that indicated hypoinsulinaemia, as well as further observation of the animals, was requested until restoring physiological reference values of insulin. The other studies mentioned that the metabolic pattern in induced or spontaneous hepatic lipidosis and ketosis included low serum insulin concentration and plasma glucose (Veenhuizen ; Drackley, 1999; Khalphallah ). Cows with primary ketosis have a low concentration of plasma glucose and insulin (Hejel ). A reduced insulin concentration further facilitated the net mobilisation of adipose tissue and thus increased the hepatic uptake of fatty acids, as reviewed by Hayirli (2006). Agenäs added that reduced feed intake leads to a rapid decrease in glucose and insulin concentrations.

The current work revealed the high efficacy of therapy in ketotic cows with insulin (200 IU SC) parallel with IV glucose 50% (500 ml) and dexamethasone (20 mg/450 kg) once daily every other day. This regime should be used alternatively with dextrose 50% and for successive 5 days. Sakai stated that ketotic cows treated with daily intravenous glucose recovered later than those treated with intravenous glucose and subcutaneous insulin injection for 4 days. Furthermore, Radostits and Constable supported the current results. They reported that cows' response with primary ketosis to treatment with corticosteroids and IV glucose was superior to therapy with corticosteroids or IV glucose alone, with fewer relapses. Other reports added that insulin enhanced cellular uptake of glucose, inhibit lipolysis and stimulated hepatic gluconeogenesis. It was administered together with either glucose, or a glucocorticoid and might be efficient in early-onset ketosis, which was not responded to glucose or corticosteroid (Djokovic ; Radostits ); consequently, IV dextrose administration should always be considered as a dual treatment of glucose and insulin (Djokovic ; Constable ).

Tufani concluded that hormonal therapy with dexamethasone or nandrolone associated with parenteral glucose and B-complex (B1, B2 and B3) provided an excellent recovery rate and significantly less evidence of relapse. McArt added that Oral propylene glycol administration was effective sharply preventive for ketosis prevention and treatment in dairy cows and produced a prominent elevation in milk yield.

The importance of administration of exogenous insulin in bovine ketosis therapy that was concluded in the present article was confirmed by Hayirli and Hayirli (2006), who said that the occurrence of lowered responsiveness and sensitivity of extrahepatic tissues to insulin as a result of NEB should be relieved by improving nutritional status, which increases the efficiency of exogenous insulin for treating hepatic lipidosis and ketosis to maintain health and improve performance.

Grünberg , Radostits and Grünberg stated that 500 ml of glucose solution 50% when IV administrated, it led to an increase insulin secretion and a decrease in glucagon release as well as transient hyperglycemia with lowered plasma concentration of NEFAs. Most diseased cattle showed marked improvement after IV Glucose, but relapses were reported commonly if repeated treatments were not applied.

The obtained results revealed that RQUICKI values were remarkably increased in treated cows at days 7 and 14 when their values compare with value at day 0 (pre-treatment). RQUICKI was also over the physiological reference range reported by Stengärde . The previous reports added that decreased RQUICKI values indicated reduced insulin sensitivity (Perseghin ; Rabasa-Lhoret ; Bossaert ). A negative linear relationship was proved between RQUICKI and body condition in lactating dairy cows (Holtenius and Holtenius 2007). Over-conditioned cows had been shown to have a decreased insulin response or reduced insulin sensitivity (Rukkwamsuk ; Holtenius ). The current study stated that the elevation in RQUICKI values with treatment (at days 7 and 14) in ketotic cows indicated an improvement in insulin sensitivity and the success of ketosis's therapeutic program. In contrast, the previous articles reported that RQUICKI values were not correlated with insulin sensitivity in ketotic cows and cattle with signs of puerperal metritis (Kerestes ).

Here, the reported results said that the insulin sensitivity was improved on therapy in ketotic cows that indicated the high efficacy of the applied therapeutic regimen. The other previous report stated that cows with ketosis had low tissue responsiveness to insulin (Grünberg ), and ketoacidosis was one reason for insulin resistance (Van Putten ; Steen ).

The importance of estimation of serum gastrin, pepsinogen and chloride here were due to the complications which occurred as a consequence to ketosis in the present study as out of the 20 (100%) cow, 8 (40%) was suffering from DA and 5 (25%) was suffering from the retained placenta, and 2 (10%) was suffering from mastitis. 5 (25%) of the cows had no complications. On the other hand, the reported results mentioned several changes in abomasal functions monitors, including gastrin, pepsinogen and chlorides. Generally, an improvement of the abomasal functions was reported as out of the ketotic cows (n = 20), many cows (n = 13) were associated with DA and other fatty liver-related diseases (retained placenta), and therefore, the changes in abomasal function monitors was related to the recovery of ketotic cattle and the high efficacy of the therapeutic strategy. The current study stated that serum gastrin value was significantly increased in post-treated ketotic cows at days 7 and 14. Throughout the study, gastrin levels in ketotic cow had higher serum gastrin concentration than the physiological reference range mentioned by Perry and Ok . Khalphallah stated that serum gastrin levels in DA cow with SCK and DA with CK either before or after operation were higher than the physiological reference values of blood gastrin in cows. Ozturk stated an elevation in serum gastrointestinal motility hormone concentrations, including ghrelin, motilin and gastrin in DA cattle. Increases in the serum ghrelin, motilin and gastrin concentrations were attributable to activation of gastrointestinal motility hormones to facilitate gastric emptying in impaired gastric motility and/or outlet occlusion in DA.

Serum pepsinogen concentrations were remarkably reduced after therapy, particularly on day 14. Throughout the study (pre-and post-therapy), serum pepsinogen levels in the ketotic cows were within the physiological reference values mentioned by Ohwada . Khalphallah mentioned that serum pepsinogen concentrations were not remarkably changed in DA cattle with either SCK or CK when their values at days 7 or 30 compared with those at day 0. They were within the physiological reference values. In contrast, Ohwada proved that serum pepsinogen concentrations in DA cows were remarkably decreased compared with a healthy one. Some authors thought that the estimation of pepsinogen levels in the blood could be diagnostic for cattle's abomasal changes (Mesarič ). Mesarič (2005) found that serum pepsinogen concentration was a fair reflection of the damage to the abomasal mucosa. Low or normal levels of serum pepsinogen activity (<5.0 U/l) might be useful as a predictor for low susceptibility for significant changes to the mucous membrane of the abomasum. Mesarič concluded that serum pepsinogen levels above 5.0 IU/l in cattle denote a severe injury of the abomasal mucosa.

From the obtained results in the current study, there were no significant changes in serum chlorides levels throughout the study period, either pre-treatment or post-treatment. Chloride concentrations were within the physiological reference range as recorded by Radostits . In contrast, it was reported that cows with ketosis were associated with hypochloremia, as reported by Ok .

Conclusion

The reported results revealed the high efficacy of the applied therapeutic strategy regime. The exposure of diseased ketotic dairy cattle for this therapeutic strategy greatly impacted their recovery from ketosis and improved their health and productivity status. The combination between hormonal therapy as insulin (2 ml per animal SC/48 hours for 5 days = 3 doses), and glucocorticoids as dexamethasone (0.04 mg/kg IM /48 hours for 5 days = 3 doses), as a single IM injection over a 1–3 minutes’ period following adequate fluid volume replacement (IV of 500 ml glucose solution 50%/48 hours for 5 days = 3 doses alternative with IV of 500 ml dextrose solution 50%/48 hours for 5 days = 2 doses) with drenching of propylene glycol (300 ml/12 hours for 2 days followed by 150 ml/24 hours for 3 days) for successive 5 days and IM injection of Vitamin B12 (5 ml/100 kg/48 hours for 5 days = 3 doses) led to high recovery rate and very low relapse rate for ketosis. This was reflected through clear improvement in clinical findings, milk yield rates, insulin sensitivity and abomasal function monitors. Hypoinsulinaemia was still reported until day 14, however, serum insulin was improved. Therefore, further observation (>14 days) of the animals was required until insulin levels restored their physiological reference values.